No headlines found.
Globe Newswire (Wed, 17-Dec 9:00 AM ET)
Globe Newswire (Tue, 2-Dec 9:25 AM ET)
INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic "Family Beginnings"
Globe Newswire (Fri, 28-Nov 1:05 PM ET)
INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
Globe Newswire (Tue, 25-Nov 9:00 AM ET)
INVO Fertility Announces Third Quarter 2025 Financial Results
Globe Newswire (Mon, 17-Nov 8:30 AM ET)
Globe Newswire (Mon, 27-Oct 8:30 AM ET)
Globe Newswire (Mon, 29-Sep 5:30 PM ET)
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic; The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell; and The Therapeutics segment consisting of financial information relating to acquired subsidiary, NTI.
Invo Fertility trades on the NASDAQ stock market under the symbol IVF.
As of December 24, 2025, IVF stock price declined to $0.87 with 47,466 million shares trading.
IVF has a beta of 1.04, meaning it tends to be more sensitive to market movements. IVF has a correlation of 0.02 to the broad based SPY ETF.
IVF has a market cap of $13.22 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that IVF belongs to (by Net Assets): VXF.
IVF support price is $.77 and resistance is $1.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IVF shares will trade within this expected range on the day.